Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000821995-12-000033
Filing Date
2012-05-04
Accepted
2012-05-04 08:52:49
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 CBRX FORM 10-Q a2012q110q.htm 10-Q 609148
2 EXHIBIT 31.1 a2012q1ex-311.htm EX-31.1 9068
3 EXHIBIT 31.2 a2012q1ex-312.htm EX-31.2 9285
4 EXHIBIT 32.1 a2012q1ex321.htm EX-32.1 6297
5 EXHIBIT 32.2 a2012q1ex322.htm EX-32.2 6732
  Complete submission text file 0000821995-12-000033.txt   2647335

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20120331.xml EX-101.INS 275050
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbrx-20120331.xsd EX-101.SCH 19522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbrx-20120331_cal.xml EX-101.CAL 45142
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbrx-20120331_def.xml EX-101.DEF 93981
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbrx-20120331_lab.xml EX-101.LAB 227511
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbrx-20120331_pre.xml EX-101.PRE 118340
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 12812017
SIC: 2834 Pharmaceutical Preparations